A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients @TheLancet @EBioMedicine #openaccess → https://t.co/D4aIPiR4Hb https://t.co/llSnXx3jjO
RT @EBioMedicine: A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients @TheLancet @EBio…
RT @EBioMedicine: A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients @TheLancet @EBio…
RT @EBioMedicine: A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients @TheLancet @EBio…
A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients @TheLancet @EBioMedicine #openaccess → https://t.co/lp2l5J3B64 https://t.co/hmRvu14YAR
RT @EBioMedicine: A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients @TheLancet @EBio…
A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients @TheLancet @EBioMedicine #openaccess → https://t.co/hL9EkycSn8 https://t.co/jLVugcsdLF
A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients @TheLancet @EBioMedicine Read the full #openaccess article → https://t.co/zQ5XIfVW8W https://t.co/ZAIBKUVm4q
A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients @TheLancet @EBioMedicine #openaccess → https://t.co/m4mGeqtj7u
RT @EBioMedicine: A 23 gene–based molecular #prognostic score to predict #overallsurvival of #breastcancer patients: new #openaccess work i…
A 23 gene-based molecular prognostic score precisely predicts overall survival of #BreastCancer #cancer patients. https://t.co/QhXf3MM2ZV
RT @EBioMedicine: A 23 gene–based molecular #prognostic score to predict #overallsurvival of #breastcancer patients: new #openaccess work i…
A 23 gene–based molecular #prognostic score to predict #overallsurvival of #breastcancer patients: new #openaccess work in @EBioMedicine https://t.co/3ZKnm5pW4G https://t.co/WjZV6En0yN